Study the efficacy of phalatrikadi kwath in the management of non alcoholic fatty liver disease grade 1 and grade 2

Study the efficacy of phalatrikadi kwath in the management of non alcoholic fatty liver ( grade 1 and grade 2)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/053029

Enrollment

Registered

2023-05-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K759- Inflammatory liver disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pain in the right upper quadrant/epigastric region, 2.Nausea 3.Vomiting 4.Loss of appetite 5.Burning sensation in abdomen 6.USG(whole abdomen) showing fatty infiltration of liver 7.Biochemical test,LFT findings

Exclusion criteria

Exclusion criteria: 1.Viral hepatitis 2.Autoimmune hepatitis 3.Wilson disease 4.Alfa 1 antitrypsin deficiency 5.Haemochromatosis 6.Alcoholic fatty liver 7.Pregnancy and lactation 8.Severe cardiac problem 9.Cancer patients 10.Psychiatric disorder 11.Stomach ulcer 12.Surgical interventions,if any

Design outcomes

Primary

Measure	Time frame
The symptoms of fatty liver such as loss of appetite ,nausea,vomiting will subsideTimepoint: 30 days to 6 months	—

Secondary

Measure	Time frame
The biochemical markers i.e. LFT,lipId profile will go to normal limitsTimepoint: 30 days to 6 months	—

Countries

India

Contacts

Public ContactDr Ranjan Kalita

Government Ayurvedic College and Hospitel,Jalukbari,Ghy 14,Assam

ranjankalita1972@gmail.com8638211399

Outcome results